2026 NPPES data Dermatology Physician NPI 1760607808 M.D., PH.D.
Verify on CMS →

DAVID BARZILAI, M.D., PH.D.

Dermatology Physician in WINCHESTER, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
282
Medicare Part D claims · 186 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$49.91
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DAVID BARZILAI, M.D., PH.D. is a Dermatology Physician ([object Object]) practicing in WINCHESTER, Massachusetts with a Medicare Part D prescribing footprint of 282 claims across 186 beneficiaries — 9% brand-name prescribing . Industry payments of $49.91 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DAVID BARZILAI, M.D., PH.D. filed 282 Medicare Part D claims in 2023 across WINCHESTER, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

DAVID BARZILAI, M.D., PH.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

DAVID BARZILAI, M.D., PH.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 04/16/2007

NPI 1760607808

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

282 61% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Massachusetts

How Dermatology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Dermatology Physician share within Massachusetts

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID BARZILAI, M.D., PH.D. is a Dermatology Physician provider practicing in WINCHESTER, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., PH.D.. NPI: 1760607808. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID BARZILAI, M.D., PH.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D., PH.D. credentials at 955 MAIN ST STE G6, WINCHESTER, MA, 01890, with a listed phone of (781) 729-4878. NPI 1760607808 was issued on 04/16/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARZILAI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 282 prescription claims written by this provider, covering 186 Medicare beneficiaries and totaling roughly $8K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

955 MAIN ST STE G6
WINCHESTER, MA 01890

Provider Details

NPI 1760607808
Specialty Dermatology Physician
Credentials M.D., PH.D.
Gender Male
NPI Issued 04/16/2007

Hospital and facility affiliations

Facilities where DAVID BARZILAI, M.D., PH.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CAMBRIDGE PUBLIC HEALTH COMMISSION
SOMERVILLE, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DAVID BARZILAI, M.D., PH.D.. Source: openpaymentsdata.cms.gov.

Total received

$50

Largest payer

Arcutis Biotherapeutics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to DAVID BARZILAI, M.D., PH.D.. To verify DAVID BARZILAI, M.D., PH.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

DAVID BARZILAI, M.D., PH.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 282 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

282
Total Claims
$8K
Total Drug Cost
186
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
314
Total Day Supply
7,789
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$2K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
75.2 years
Avg HCC Risk Score
0.95
Gender Split
34% female / 66% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Mupirocin
83
Triamcinolone Acetonide
78
Ketoconazole
40
Metronidazole
40

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How DAVID BARZILAI, M.D., PH.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

DAVID BARZILAI, M.D., PH.D.'s 282 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BARZILAI.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID BARZILAI, M.D., PH.D.'s specialty?
DAVID BARZILAI, M.D., PH.D. specializes in Dermatology Physician and practices in WINCHESTER, Massachusetts. Credentials: M.D., PH.D..
How much does DAVID BARZILAI, M.D., PH.D. prescribe under Medicare Part D?
In 2023, DAVID BARZILAI, M.D., PH.D. wrote 282 Medicare Part D claims totaling $8K in drug costs for 186 beneficiaries.
Where is DAVID BARZILAI, M.D., PH.D. located?
DAVID BARZILAI, M.D., PH.D. is located at 955 MAIN ST STE G6, WINCHESTER, MA, 01890. Phone: (781) 729-4878.
What is DAVID BARZILAI, M.D., PH.D.'s NPI number?
DAVID BARZILAI, M.D., PH.D.'s National Provider Identifier (NPI) is 1760607808, issued on 04/16/2007.
Does DAVID BARZILAI, M.D., PH.D. prescribe more brand-name or generic drugs?
DAVID BARZILAI, M.D., PH.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $2K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does DAVID BARZILAI, M.D., PH.D. prescribe most often?
Based on 2023 Medicare Part D data, DAVID BARZILAI, M.D., PH.D.'s most frequently prescribed drugs include Mupirocin, Triamcinolone Acetonide, Ketoconazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID BARZILAI, M.D., PH.D. accept Medicare?
DAVID BARZILAI, M.D., PH.D. appears in CMS Medicare data with 282 Part D claims and 186 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID BARZILAI, M.D., PH.D.'s credentials?
DAVID BARZILAI, M.D., PH.D.'s NPI is 1760607808 with credentials M.D., PH.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology